Cutaneous Leishmania infection: Progress in pathogenesis research and experimental therapy

55Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Studies in murine experimental Leishmania major infection have helped to understand the requirements for efficient development of T helper (Th)1/cytotoxic T (Tc)1-mediated protection against the parasite. As such they have revealed that Fcγ receptor (FcγR)I and Fcγ RIII-mediated uptake of L. major amastigotes by dendritic cells (DC) is an important prerequisite for Th1 development. In addition, DC-derived cytokines contribute to adequate T-cell education. DC-based vaccines may thus provide an important tool for both the development of a prophylactic vaccine against leishmaniasis and - together with leishmanicidal drugs - for eliciting immune-deviating functions towards protective immunity in non-healing leishmaniasis. This review highlights recent advances in the understanding of the role of DC for the induction of Th1/Tc1-predominant immunity against L. major and how this knowledge may translate into clinical approaches. © 2007 The Authors Journal compilation 2007 Blackwell Munksgaard.

Cite

CITATION STYLE

APA

Von Stebut, E. (2007). Cutaneous Leishmania infection: Progress in pathogenesis research and experimental therapy. Experimental Dermatology, 16(4), 340–346. https://doi.org/10.1111/j.1600-0625.2007.00554.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free